ResearcherAmsterdam University Medical CentersNo recent work listed
Marin Strijker
Matched on ORCID iD 0000-0003-4988-9624; OpenAlex author ID A5043191979. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 56
2019: 1 paper · 2020: 3 papers · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper
Papers 7
- Serum levels of iCAF-derived osteoglycin predict favorable outcome in pancreatic cancer. Co-author DOI 10.1002/ijc.34276↗
- Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS-2 multicentre study. Co-author DOI 10.1093/bjs/znac272↗
- Readily available biomarkers predict poor survival in metastatic pancreatic cancer. Co-author DOI 10.1080/1354750x.2021.1893814↗
- Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ijc.32586↗
- International validation and update of the Amsterdam model for prediction of survival after pancreatoduodenectomy for pancreatic cancer. First author DOI 10.1016/j.ejso.2019.12.023↗
- Establishing and Coordinating a Nationwide Multidisciplinary Study Group: Lessons Learned by the Dutch Pancreatic Cancer Group. Co-author DOI 10.1097/sla.0000000000003779↗
- Systematic review of clinical prediction models for survival after surgery for resectable pancreatic cancer. Co-author DOI 10.1002/bjs.11111↗
Closest collaborators
The 25 strongest of 56 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Marc G. Besselink · 7 shared papers, 2019–2023 · strength 0.71
- Paper Serum levels of iCAF-derived osteoglycin predict favorable outcome in pancreatic cancer. DOI 10.1002/ijc.34276↗
- Paper Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS… DOI 10.1093/bjs/znac272↗
- Paper Readily available biomarkers predict poor survival in metastatic pancreatic cancer. DOI 10.1080/1354750x.2021.1893814↗
- Hanneke W.M. van Laarhoven · 6 shared papers, 2019–2023 · strength 0.63
- Paper Serum levels of iCAF-derived osteoglycin predict favorable outcome in pancreatic cancer. DOI 10.1002/ijc.34276↗
- Paper Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS… DOI 10.1093/bjs/znac272↗
- Paper Readily available biomarkers predict poor survival in metastatic pancreatic cancer. DOI 10.1080/1354750x.2021.1893814↗
- Maarten F. Bijlsma · 4 shared papers, 2020–2023 · strength 0.44
- Paper Serum levels of iCAF-derived osteoglycin predict favorable outcome in pancreatic cancer. DOI 10.1002/ijc.34276↗
- Paper Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS… DOI 10.1093/bjs/znac272↗
- Paper Readily available biomarkers predict poor survival in metastatic pancreatic cancer. DOI 10.1080/1354750x.2021.1893814↗
- Casper H.J. van Eijck · 4 shared papers, 2019–2023 · strength 0.40
- Paper Serum levels of iCAF-derived osteoglycin predict favorable outcome in pancreatic cancer. DOI 10.1002/ijc.34276↗
- Paper Establishing and Coordinating a Nationwide Multidisciplinary Study Group: Lessons Learned by the Dutch Pancreatic Cance… DOI 10.1097/sla.0000000000003779↗
- Paper Systematic review of clinical prediction models for survival after surgery for resectable pancreatic cancer. DOI 10.1002/bjs.11111↗
- Johanna W. Wilmink · 4 shared papers, 2019–2021 · strength 0.38
- Paper Readily available biomarkers predict poor survival in metastatic pancreatic cancer. DOI 10.1080/1354750x.2021.1893814↗
- Paper Establishing and Coordinating a Nationwide Multidisciplinary Study Group: Lessons Learned by the Dutch Pancreatic Cance… DOI 10.1097/sla.0000000000003779↗
- Paper Systematic review of clinical prediction models for survival after surgery for resectable pancreatic cancer. DOI 10.1002/bjs.11111↗
- Izaak Quintus Molenaar · 3 shared papers, 2020–2023 · strength 0.35
- Paper Serum levels of iCAF-derived osteoglycin predict favorable outcome in pancreatic cancer. DOI 10.1002/ijc.34276↗
- Paper Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS… DOI 10.1093/bjs/znac272↗
- Paper Establishing and Coordinating a Nationwide Multidisciplinary Study Group: Lessons Learned by the Dutch Pancreatic Cance… DOI 10.1097/sla.0000000000003779↗
- Bert A. Bonsing · 3 shared papers, 2020–2023 · strength 0.35
- Paper Serum levels of iCAF-derived osteoglycin predict favorable outcome in pancreatic cancer. DOI 10.1002/ijc.34276↗
- Paper Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS… DOI 10.1093/bjs/znac272↗
- Paper Establishing and Coordinating a Nationwide Multidisciplinary Study Group: Lessons Learned by the Dutch Pancreatic Cance… DOI 10.1097/sla.0000000000003779↗
- Joanne Verheij · 3 shared papers, 2020–2022 · strength 0.31
- Paper Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS… DOI 10.1093/bjs/znac272↗
- Paper Readily available biomarkers predict poor survival in metastatic pancreatic cancer. DOI 10.1080/1354750x.2021.1893814↗
- Paper Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal ade… DOI 10.1002/ijc.32586↗
- Bas Groot Koerkamp · 3 shared papers, 2019–2020 · strength 0.26
- Paper Establishing and Coordinating a Nationwide Multidisciplinary Study Group: Lessons Learned by the Dutch Pancreatic Cance… DOI 10.1097/sla.0000000000003779↗
- Paper Systematic review of clinical prediction models for survival after surgery for resectable pancreatic cancer. DOI 10.1002/bjs.11111↗
- Paper International validation and update of the Amsterdam model for prediction of survival after pancreatoduodenectomy for p… DOI 10.1016/j.ejso.2019.12.023↗
- Mark P.G. Dings · 2 shared papers, 2022–2023 · strength 0.25
- Nadia Haj Mohammad · 2 shared papers, 2021–2023 · strength 0.25
- Ignace H. J. T. de Hingh · 2 shared papers, 2020–2023 · strength 0.23
- Marco J. Bruno · 2 shared papers, 2020–2023 · strength 0.23
- Eline C. Soer · 2 shared papers, 2020–2022 · strength 0.19
- Paper Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS… DOI 10.1093/bjs/znac272↗
- Paper Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal ade… DOI 10.1002/ijc.32586↗
- Frederike Dijk · 2 shared papers, 2020–2022 · strength 0.19
- Paper Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS… DOI 10.1093/bjs/znac272↗
- Paper Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal ade… DOI 10.1002/ijc.32586↗
- Jesse V. Groen · 2 shared papers, 2020–2022 · strength 0.19
- Paper Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS… DOI 10.1093/bjs/znac272↗
- Paper International validation and update of the Amsterdam model for prediction of survival after pancreatoduodenectomy for p… DOI 10.1016/j.ejso.2019.12.023↗
- Jeanin Elise van Hooft · 2 shared papers, 2020–2021 · strength 0.19
- Matteo De Pastena · 2 shared papers, 2020 · strength 0.16
- Paper Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal ade… DOI 10.1002/ijc.32586↗
- Paper International validation and update of the Amsterdam model for prediction of survival after pancreatoduodenectomy for p… DOI 10.1016/j.ejso.2019.12.023↗
- Giovanni Marchegiani · 2 shared papers, 2020 · strength 0.16
- Paper Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal ade… DOI 10.1002/ijc.32586↗
- Paper International validation and update of the Amsterdam model for prediction of survival after pancreatoduodenectomy for p… DOI 10.1016/j.ejso.2019.12.023↗
- Sophie C. Lodestijn · 1 shared paper, 2023 · strength 0.14
- Louis Vermeulen · 1 shared paper, 2023 · strength 0.14
- Michail Doukas · 1 shared paper, 2023 · strength 0.14
- Paul Manoukian · 1 shared paper, 2023 · strength 0.14
- Hans Morreau · 1 shared paper, 2022 · strength 0.12
- G. Johan A. Offerhaus · 1 shared paper, 2022 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.